- Release Date: 03/12/20 08:25
- Summary: Overview of ProstACT Phase III Study - Investor supplement
- Price Sensitive: No
- Download Document 8.92MB
- Forums
- ASX - By Stock
- TLX
- Ann: Overview of ProstACT Phase III Study - Investor supplement
Ann: Overview of ProstACT Phase III Study - Investor supplement
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.32 |
Change
-0.030(0.16%) |
Mkt cap ! $6.103B |
Open | High | Low | Value | Volume |
$18.35 | $18.53 | $18.16 | $12.43M | 679.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1188 | $18.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.32 | 1774 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1188 | 18.310 |
1 | 431 | 18.300 |
2 | 1054 | 18.290 |
2 | 2496 | 18.270 |
1 | 345 | 18.260 |
Price($) | Vol. | No. |
---|---|---|
18.320 | 1774 | 1 |
18.330 | 1061 | 1 |
18.360 | 3331 | 1 |
18.370 | 4656 | 2 |
18.380 | 251 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online